What Happened?
, -based ImmPACT Bio USA Appointed Vikram Lamba as Chief Financial Officer and Head of Business Development
About the Company
ImmPACT-Bio is pioneering a novel strategy to surmount a major challenge compromising current Chimeric Antigen Receptor T-cell (CAR-T) therapy. Our technology addresses the need to differentiate cancerous from non-cancerous tissues impacting the safety of the treatment which is to date a major limitation in reaching effectiveness.
About the Person
Vikram Lamba is Chief Financial Officer and Head of Business Development at ImmPACT Bio USA. Previously, Vikram held various senior HR leadership roles in the industry.
Info Source
News
Short Profile